Literature DB >> 27814881

Commentary on "Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer." Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM, University of Washington-Urology, Seattle, WA. Nat Commun 2015; 6:6605.

Daniel Lin1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27814881     DOI： 10.1016/j.urolonc.2016.02.005

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


× No keyword cloud information.
  16 in total

Review 1.  Translational and clinical implications of the genetic landscape of prostate cancer.

Authors:  Daniel E Spratt; Zachary S Zumsteg; Felix Y Feng; Scott A Tomlins
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

Review 2.  Metastasis as a systemic disease: molecular insights and clinical implications.

Authors:  Maša Alečković; Sandra S McAllister; Kornelia Polyak
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-06-14       Impact factor: 10.680

3.  Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor.

Authors:  Michael J Hwang; Kelly G Bryant; Jae H Seo; Qin Liu; Peter A Humphrey; Mary Ann C Melnick; Dario C Altieri; Marie E Robert
Journal:  Am J Pathol       Date:  2019-05-09       Impact factor: 4.307

Review 4.  Limiting tumor seeding as a therapeutic approach for metastatic disease.

Authors:  Asurayya Worrede; Olimpia Meucci; Alessandro Fatatis
Journal:  Pharmacol Ther       Date:  2019-03-12       Impact factor: 12.310

5.  Triple Aberrant Prostate Cancer (TAPC) - Aggregate role of aberrations in TP53, PTEN and RB1 on ETS gene fusions and prognosis in metastatic castrate resistant prostate cancer.

Authors:  Allison P Watson; Ashraf Shabaneh; Jinhua Wang; Scott M Dehm; Arpit Rao; Charles J Ryan
Journal:  Am J Clin Exp Urol       Date:  2020-08-15

6.  Integrative clinical genomics of advanced prostate cancer.

Authors:  Dan Robinson; Eliezer M Van Allen; Yi-Mi Wu; Nikolaus Schultz; Robert J Lonigro; Juan-Miguel Mosquera; Bruce Montgomery; Mary-Ellen Taplin; Colin C Pritchard; Gerhardt Attard; Himisha Beltran; Wassim Abida; Robert K Bradley; Jake Vinson; Xuhong Cao; Pankaj Vats; Lakshmi P Kunju; Maha Hussain; Felix Y Feng; Scott A Tomlins; Kathleen A Cooney; David C Smith; Christine Brennan; Javed Siddiqui; Rohit Mehra; Yu Chen; Dana E Rathkopf; Michael J Morris; Stephen B Solomon; Jeremy C Durack; Victor E Reuter; Anuradha Gopalan; Jianjiong Gao; Massimo Loda; Rosina T Lis; Michaela Bowden; Stephen P Balk; Glenn Gaviola; Carrie Sougnez; Manaswi Gupta; Evan Y Yu; Elahe A Mostaghel; Heather H Cheng; Hyojeong Mulcahy; Lawrence D True; Stephen R Plymate; Heidi Dvinge; Roberta Ferraldeschi; Penny Flohr; Susana Miranda; Zafeiris Zafeiriou; Nina Tunariu; Joaquin Mateo; Raquel Perez-Lopez; Francesca Demichelis; Brian D Robinson; Marc Schiffman; David M Nanus; Scott T Tagawa; Alexandros Sigaras; Kenneth W Eng; Olivier Elemento; Andrea Sboner; Elisabeth I Heath; Howard I Scher; Kenneth J Pienta; Philip Kantoff; Johann S de Bono; Mark A Rubin; Peter S Nelson; Levi A Garraway; Charles L Sawyers; Arul M Chinnaiyan
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

7.  SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines.

Authors:  So Young Choi; Ju Mi Jeon; Ann Yae Na; Oh Kwang Kwon; In Hyuk Bang; Yun-Sok Ha; Eun Ju Bae; Byung-Hyun Park; Eun Hye Lee; Tae Gyun Kwon; Jun Nyung Lee; Sangkyu Lee
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

8.  A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer.

Authors:  Jung Ki Jo; Jong Jin Oh; Yong Tae Kim; Hong Sang Moon; Hong Yong Choi; Seunghyun Park; Jin-Nyoung Ho; Sungroh Yoon; Hae Young Park; Seok-Soo Byun
Journal:  Oncotarget       Date:  2017-05-30

Review 9.  Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.

Authors:  Anton M F Kalsbeek; Eva K F Chan; Niall M Corcoran; Christopher M Hovens; Vanessa M Hayes
Journal:  Oncotarget       Date:  2017-08-04

Review 10.  Molecular determinants of prostate cancer metastasis.

Authors:  Kiera Rycaj; Dean G Tang
Journal:  Oncotarget       Date:  2017-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.